AIM
AIM ImmunoTech Inc. · Healthcare · Market cap $4.9M
Insiders bought $19K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 23, 2026
Insider Buying
$19K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Oct 23, 2026
Equels Thomas K
AIM ImmunoTech Inc. (AIM) has 8 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 23, 2026.
Inside the rolling window, 1 insider at AIM ImmunoTech Inc. reported 5 open-market purchases totaling $19K and no open-market sales. The most active filer is CEO & President Equels Thomas K with 5 filings. The most recent open-market filing is a purchase of 31,250 shares by CEO & President Equels Thomas K, dated Oct 22, 2026, worth $5K.
- Industry:Biotechnology
- CEO:Thomas K. Equels
- Employees:19
- HQ:Ocala, FL, US
- IPO:1995-11-02
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does AIM have?
AIM ImmunoTech Inc. (AIM) has 8 SEC Form 4 filings (8 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 23, 2026.
When was the most recent SEC Form 4 filing for AIM?
The most recent Form 4 filing for AIM on Tracefour is dated Oct 23, 2026.
Who is the most active insider at AIM?
The most active SEC Form 4 filer at AIM in the rolling window is CEO & President Equels Thomas K, with 5 filings.
What is the net insider flow at AIM over the last 6 months?
Over the trailing 180 days, insiders at AIM have net bought $19K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AIM in the current window?
Inside the rolling window, insiders at AIM bought $19K and sold $0 based on SEC Form 4 filings.
Can I get alerts for AIM insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at AIM ImmunoTech Inc. (AIM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
AIM ImmunoTech Inc. is in the Healthcare sector.